PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients 2-5 Years Old

Jun 10, 2019

Posted by PTC Therapeutics, Inc.

Inaugural Element Series Event: Accelerating Science through Innovation

Jun 06, 2019

Posted by Elemental Machines

REGENXBIO® Selects Skyland PIMS™ as their Process and Product Data Management System

Jun 04, 2019

BioIVT HEPATOPAC® Meeting to Highlight Advances in Drug Discovery Research

Jun 03, 2019

Posted by BioIVT

PTC Therapeutics Promotes Emily Hill to Chief Financial Officer

Jun 03, 2019

Posted by PTC Therapeutics, Inc.

PTC Therapeutics to Present at the Jefferies Healthcare Conference on June 6

May 30, 2019

Posted by PTC Therapeutics, Inc.

PickR™ V1.0 released: A new solution for the selection of diverse R-groups for library design and better intellectual property

May 29, 2019

Posted by Cresset